PharmaVoice Logo

Healthcare Leaders Hub

TwoStep Therapeutics secures $62.5m funding to advance TS-104

Pharma Tech

TwoStep Therapeutics secures $62.5m funding to advance TS-104

TwoStep Therapeutics has raised $62.5m in Series A financing to support its lead peptide-drug conjugate, TS-104, to treat solid tumours.

Read Full Article
 MSD inaugurates Technology Centre in Hyderabad

Express Pharma

 MSD inaugurates Technology Centre in Hyderabad

MSD, a  global biopharmaceutical leader, inaugurated its new 2.5 lakh sq. ft Technology Centre in  Hyderabad, further strengthening the city’s position as a global hub for life sciences, technology and  […] The post  MSD inaugurates Technology Centre in Hyderabad appeared first on Express Pharma.

Read Full Article
Fredun Pharmaceuticals acquires Furlicks from pharma major USV

Express Pharma

Fredun Pharmaceuticals acquires Furlicks from pharma major USV

Fredun Pharmaceuticals Limited (FPL), has acquired Furlicks, an innovative pet-wellness brand focused on convenient, easy-to-administer oral-strip solutions for pets. The acquisition of Furlicks from USV & Wellbeing Nutrition brings the brand’s differentiated product innovation and consumer understanding into […] The post Fredun Pharmaceuticals acquires Furlicks from pharma major USV appeared first on Express Pharma.

Read Full Article
Why China’s rise needs to be taken with a pinch of salt

Pharma Tech

Why China’s rise needs to be taken with a pinch of salt

Though recent dealmaking illustrates China’s rapid rise in global biopharma, experts suggest this could be about to plateau.

Read Full Article
Pharma’s R&D, commercial approach shifts amid global policy evolution

Pharma Tech

Pharma’s R&D, commercial approach shifts amid global policy evolution

A survey of 175 pharma executives highlights an increasing reluctance to launch in lower-value markets, alongside a heightened focus on RWE.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Sep 10, 2026, 8:30 AM

Emboline Receives US FDA 510(k) Clearance for Emboliner Embolic Protection System

Shots: Ref: PRnewswire  | Image: Emboline  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Emboline Receives US FDA 510(k) Clearance for Emboliner Embolic Protection System appeared first on PharmaShots.

Pharma Tech

Sep 10, 2026, 8:14 AM

TwoStep Therapeutics secures $62.5m funding to advance TS-104

TwoStep Therapeutics has raised $62.5m in Series A financing to support its lead peptide-drug conjugate, TS-104, to treat solid tumours.

Express Pharma

Sep 10, 2026, 6:40 AM

 MSD inaugurates Technology Centre in Hyderabad

MSD, a  global biopharmaceutical leader, inaugurated its new 2.5 lakh sq. ft Technology Centre in  Hyderabad, further strengthening the city’s position as a global hub for life sciences, technology and  […] The post  MSD inaugurates Technology Centre in Hyderabad appeared first on Express Pharma.

PharmaShots

Sep 10, 2026, 6:30 AM

Bayer’s Hyrnuo (Sevabertinib) Gains the US FDA Accelerated Approval for 1L Treatment of Non-Squamous HER2-Mutated NSCLC

Shots: Ref: Businesswire | Image: Bayer | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Bayer’s Hyrnuo (Sevabertinib) Gains the US FDA Accelerated Approval for 1L Treatment of Non-Squamous HER2-Mutated NSCLC appeared first on PharmaShots.

PharmaShots

Sep 10, 2026, 6:30 AM

Lee’s Pharm Licenses 1cBio’s OC-3 in China and Southeast Asia

Shots: Ref: PRnewswire | Image: 1cBio & Lee’s Pharm  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Lee’s Pharm Licenses 1cBio’s OC-3 in China and Southeast Asia appeared first on PharmaShots.

ET Pharma

Sep 10, 2026, 6:27 AM

Novartis twin drug trial setbacks pile pressure on pipeline, CEO

The setback for del-desiran, which Novartis acquired through its recent $12 billion acquisition of Avidity, increases pressure on CEO Vas Narasimhan and his M&A strategy to build up the firm's pipeline.

News

Latest industry coverage

Google News

Sep 10, 2026, 9:15 AM

Musings from The Power List: Ali Tavassoli - The Medicine Maker

Musings from The Power List: Ali Tavassoli  The Medicine Maker

Google News

Sep 10, 2026, 8:55 AM

Life Science Tools Market Size & Share Report, 2026-2033 - Grand View Research

Life Science Tools Market Size & Share Report, 2026-2033  Grand View Research

Google News

Sep 10, 2026, 8:54 AM

Despite the all-time performance of technology exports, K-bio, which has relied on early licensing o.. - 매일경제

Despite the all-time performance of technology exports, K-bio, which has relied on early licensing o..  매일경제

Google News

Sep 10, 2026, 8:30 AM

Pharma’s most expensive question is the last one asked - pharmaphorum

Pharma’s most expensive question is the last one asked  pharmaphorum

Google News

Sep 10, 2026, 8:19 AM

TwoStep Therapeutics secures $62.5m funding to advance TS-104 - Pharmaceutical Technology

TwoStep Therapeutics secures $62.5m funding to advance TS-104  Pharmaceutical Technology

Google News

Sep 10, 2026, 8:16 AM

Pharmaceutical Packaging Market - Yahoo Finance

Pharmaceutical Packaging Market  Yahoo Finance

Google News

Sep 10, 2026, 8:10 AM

Pharma Companies Turn to Strategic CDMO Partnerships as Development Needs Evolve - The National Law Review

Pharma Companies Turn to Strategic CDMO Partnerships as Development Needs Evolve  The National Law Review

Google News

Sep 10, 2026, 8:06 AM

Hong Kong ready to be biotech bridge, says Paul Chan - RTHK News

Hong Kong ready to be biotech bridge, says Paul Chan  RTHK News

Google News

Sep 10, 2026, 8:05 AM

Samsung Biologics Inks $262M Biologics Contract with European Pharma - 조선일보

Samsung Biologics Inks $262M Biologics Contract with European Pharma  조선일보

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer